Archive Newsletter

  1. 03.16.26 -- From Discovery To AAV Production: Tools To Accelerate Gene Therapy 3/16/2026

    03/16/26 Cell & Gene Newsletter

  2. 03.16.26 -- Not So Fast Into The Night: Your Outsourcing Needs A Pause 3/16/2026
    03/16/26 Cell & Gene Newsletter
  3. 03.14.26 -- Cell & Gene Best Of February 3/14/2026
    03/14/26 Cell & Gene Newsletter
  4. 03.13.26 -- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead 3/13/2026
    03/13/26 Cell & Gene Newsletter
  5. 03.12.26 -- Six Specialized Modalities Testing CDMO Readiness In 2026 3/12/2026
    03/12/26 Cell & Gene Newsletter
  6. 03.11.26 -- Are You Scaling CGT Wrong? 3/11/2026

    03/11/26 Cell & Gene Newsletter

  7. 03.11.26 -- Regulators Maintain Consistent Endpoints While Raising Evidence Standards 3/11/2026
    03/11/26 Cell & Gene Newsletter
  8. 03.10.26 -- STREAM Edition: mRNA Hot Takes: Fighting Complacency And "Alternative Facts" In 2026 3/10/2026

    03/10/26 Cell & Gene Newsletter

  9. 03.10.26 -- The Real Reason We Haven't Fully Automated Cell Therapy Yet 3/10/2026
    03/10/26 Cell & Gene Newsletter
  10. 03.09.26 -- Putting Pressure On CDMOs With Herman Bozenhardt 3/9/2026
    03/09/26 Cell & Gene Newsletter